醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
RGEN · REPLIGEN CORP
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
REPLIGEN CORP（RGEN）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $6.0M；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-06。
買入 Bought—
賣出 Sold$6.0M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-05 | Loeillot Olivier Chief Executive Officer, Director | 賣出 Sell | 5,535 | $187.29 | $1.0M | SEC |
| 2026-09-24 | Loeillot Olivier Chief Executive Officer, Director | 賣出 Sell | 12,946 | $190.00 | $2.5M | SEC |
| 2026-09-21 | Loeillot Olivier Chief Executive Officer, Director | 賣出 Sell | 5,426 | $180.00 | $977K | SEC |
| 2026-09-04 | Loeillot Olivier Chief Executive Officer, Director | 賣出 Sell | 3,035 | $165.90 | $504K | SEC |
| 2026-08-20 | Loeillot Olivier Chief Executive Officer, Director | 賣出 Sell | 5,426 | $180.00 | $977K | SEC |
| 2026-07-16 | Garland Jason K CFO | 賣出 Sell | 530 | $150.00 | $80K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-05 | Loeillot Olivier Officer, Director | 4,202 | $798K | 10b5-1 |
| 2026-10-05 | Loeillot Olivier Officer, Director | 1,333 | $238K | 10b5-1 |
| 2026-09-24 | Loeillot Olivier Officer, Director | 12,946 | $2.5M | 10b5-1 |
| 2026-09-21 | Loeillot Olivier Officer, Director | 5,426 | $977K | 10b5-1 |
| 2026-09-04 | Loeillot Olivier Officer, Director | 3,035 | $504K | 10b5-1 |
| 2026-08-20 | Loeillot Olivier Officer, Director | 5,426 | $977K | 10b5-1 |
| 2026-07-16 | Garland Jason K Officer | 530 | $80K | 10b5-1 |
內部人 Insiders
Loeillot Olivier、Garland Jason K